SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, today announced that company management will participate in the following investor conferences in September:
Alumis to Participate in Upcoming September Investor Conferences
ALUMIS INC
NASDAQ:ALMS (2/7/2025, 8:11:20 PM)
After market: 5.95 +0.28 (+4.94%)5.67
-0.92 (-13.96%)
ALMS Latest News and Analysis
17 hours ago - ChartmillWhat's going on in today's pre-market sessionDiscover the top movers in Friday's pre-market session and stay informed about market dynamics.
